Yanes QM

Language: Spanish
References: 10
Page: 174-177
PDF size: 59.06 Kb.

ABSTRACT

Primary hyperaldosteronism is one of the potentially curable secondary blood hypertension forms of endocrine etiology. This disease was firstly described by Jerome Conn in 1955 and characterized by high production of aldosterone with relative autonomy of the renin-angiotensin system. This disease may be suspected in patients with blood hypertension with or without hypokalemia and confirmed with the increase of aldosteron/plasma rennin activity index. The treatment of choice is surgery, but the use of antagonist agents of mineralocorticoids can be another therapeutic alternative before the surgery or when this procedure is not possible.

REFERENCES

1. Sánchez R, Ayala M, Baglivo H, Velázquez C, Burlando G, Kohlmann O, Zanchetti, A. Guías Latinoamericanas de Hipertensión Arterial. Revista Chilena de Cardiología. 2010;29(1):117-44.

2. Builes C, Sierra J. Hipertensión secundaria por hiperaldosteronismo primario. Acta Médica Colombiana. 2013;38(2):86-90.

3. Waisman G. Hipertensión arterial resistente. Rev Fed Arg Cardiol. 2013;42(3):170-3.

4. Conn JW. Presidential address. I. Painting background II. Primary aldosteronism, a new clinical syndrome 1955. J Lab Clin Med. 1955;45:3-17.

5. Conn JW, Cohen EL, Rovner DR, Nesbit RM. Normokalemic primary aldosteronism: a detectable cause of curable “essential” hypertension. JAMA. 1965;193:200-6.

6. Pardes E, Belli S, Cornaló D, Contreras L, Costa L, Chervin R, et al. Determinación del valor de corte de la relación aldosterona/actividad de renina plasmática para la detección de hiperaldosteronismo primario en hipertensión arterial esencial: estudio multicéntrico. RAEM. 2009;47(2):121-3.

7. Morries MT. Hiperaldosteronismo primario. Medicine. 2008;10(15): 976-80.

8. Fallo F, Vegilio F, Bertello CH, Sonino N, Mea PD Ermani M, et al. Prevalence the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab. 2006;91:45-9.

9. Arranz A. Mineralocorticoides. Hiperaldosteronismo. En: Albarran A. Endocrinología. Madrid: Editorial Médica Panamericana; 2011. p. 317-29.

10. Luque M, Alpañés M, Álvarez F, Escobar H. Hiperaldosteronismo primario y secundario. Medicina-Programa de Formación Médica Continuada Acreditado. 2012;11(15):871-82.